{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:15:23Z","timestamp":1771373723256,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T00:00:00Z","timestamp":1419206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114923","type":"journal-article","created":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T18:56:25Z","timestamp":1419274585000},"page":"e114923","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Olmesartan Decreased Levels of IL-1\u03b2 and TNF-\u03b1, Down-Regulated MMP-2, MMP-9, COX-2, RANK\/RANKL and Up-Regulated SOCs-1 in an Intestinal Mucositis Model"],"prefix":"10.1371","volume":"9","author":[{"given":"Raimundo Fernandes de","family":"Ara\u00fajo J\u00fanior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Patr\u00edcia Oliveira","family":"da Silva Reinaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerly Anne de Castro","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro de Fran\u00e7a","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Aur\u00e9lio de Moura","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Addison Xavier","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurigena Antunes","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"ST Sonis","year":"2004","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"ST Sonis","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11912-003-0098-3","article-title":"Novel antifolate drugs","volume":"5","author":"WT Purcell","year":"2003","journal-title":"Curr Oncol Rep"},{"key":"ref4","first-page":"S5","article-title":"Mechanisms of action of methotrexate","volume":"71","author":"ES Chan","year":"2013","journal-title":"Bull Hosp Jt Dis (2013)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.etp.2009.02.120","article-title":"Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress","volume":"62","author":"M Gulgun","year":"2010","journal-title":"Exp Toxicol Pathol"},{"key":"ref6","first-page":"1850","article-title":"Adverse effects of low dose methotrexate therapy in rheumatoid arthritis","volume":"20","author":"RJ McKendry","year":"1993","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.soncn.2003.10.002","article-title":"Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis","volume":"20","author":"EB Avritscher","year":"2004","journal-title":"Semin Oncol Nurs"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/gast.2002.31068","article-title":"Biological actions and therapeutic potential of the glucagon-like peptides","volume":"122","author":"DJ Drucker","year":"2002","journal-title":"Gastroenterology"},{"key":"ref9","first-page":"159","article-title":"The diagnosis and management of cardiovascular disease in cancer patients. Foreword","volume":"33","author":"SH Rahimtoola","year":"2008","journal-title":"Curr Probl Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/hr.2009.95","article-title":"Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma","volume":"32","author":"A Nakano","year":"2009","journal-title":"Hypertens Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jcpe.12160","article-title":"Effect of telmisartan on levels of IL-1, TNF-alpha, down-regulated COX-2, MMP-2, MMP-9 and RANKL\/RANK in an experimental periodontitis model","volume":"40","author":"AA Araujo","year":"2013","journal-title":"J Clin Periodontol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00210-013-0886-8","article-title":"Olmesartan decreases IL-1beta and TNF-alpha levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis","volume":"386","author":"AA Araujo","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1590\/S0100-879X2003001000015","article-title":"Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats","volume":"36","author":"MH Souza","year":"2003","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0076-6879(90)86134-H","article-title":"Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal","volume":"186","author":"H Esterbauer","year":"1990","journal-title":"Methods Enzymol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1476-5381.1995.tb15035.x","article-title":"Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia","volume":"115","author":"B Safieh-Garabedian","year":"1995","journal-title":"Br J Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-1759(83)80022-2","article-title":"Utilization of the biotin\/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA)","volume":"56","author":"C Kendall","year":"1983","journal-title":"J Immunol Methods"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01966691","article-title":"Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity","volume":"17","author":"GE de Souza","year":"1985","journal-title":"Agents Actions"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00280-013-2115-z","article-title":"A preclinical study on the protective effect of melatonin against methotrexate-induced small intestinal damage: effect mediated by attenuation of nitrosative stress, protein tyrosine nitration, and PARP activation","volume":"71","author":"VK Kolli","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuro.2006.06.007","article-title":"Differential effects of methylmercury intoxication in the rat's barrel field as evidenced by NADPH diaphorase histochemistry","volume":"28","author":"MA Freire","year":"2007","journal-title":"Neurotoxicology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jcmm.12128","article-title":"Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis","volume":"17","author":"D Wang","year":"2013","journal-title":"J Cell Mol Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejphar.2012.10.024","article-title":"Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats","volume":"698","author":"R Refaat","year":"2013","journal-title":"European Journal of Pharmacology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1152\/ajpendo.90459.2008","article-title":"Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake","volume":"296","author":"N Boukhettala","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/00365520410003605","article-title":"Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats","volume":"39","author":"Y Miyazono","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.2003.01784.x","article-title":"Oral and intestinal mucositis - causes and possible treatments","volume":"18","author":"M Duncan","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/08037050600586593","article-title":"Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats","volume":"15","author":"S Sandmann","year":"2006","journal-title":"Blood Press"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1368-8375(03)00148-9","article-title":"The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis","volume":"40","author":"ST Sonis","year":"2004","journal-title":"Oral Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00280-006-0301-y","article-title":"Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster","volume":"59","author":"RF Leitao","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"R Visse","year":"2003","journal-title":"Circulation Research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/jpet.106.103465","article-title":"Role of matrix metalloproteinases in intestinal inflammation","volume":"318","author":"C Medina","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00011-004-1281-1","article-title":"An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice","volume":"53","author":"Y Naito","year":"2004","journal-title":"Inflamm Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1258\/ebm.2010.010082","article-title":"Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat","volume":"235","author":"N Al-Dasooqi","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Fujimoto M, Naka T (2010) SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases. Gastroenterol Res Pract 2010.","DOI":"10.1155\/2010\/470468"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(02)00449-1","article-title":"SOCS-1 participates in negative regulation of LPS responses","volume":"17","author":"R Nakagawa","year":"2002","journal-title":"Immunity"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni1012","article-title":"Suppressors of cytokine signaling and immunity","volume":"4","author":"M Kubo","year":"2003","journal-title":"Nat Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1074\/jbc.M512338200","article-title":"SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation","volume":"281","author":"Y He","year":"2006","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0167-5699(00)01718-7","article-title":"Osteoprotegerin ligand: a regulator of immune responses and bone physiology","volume":"21","author":"YY Kong","year":"2000","journal-title":"Immunol Today"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.4049\/jimmunol.0711823","article-title":"RANK-RANKL Signaling Pathway Is Critically Involved in the Function of CD4(+)CD25(+) Regulatory T Cells in Chronic Colitis","volume":"182","author":"T Totsuka","year":"2009","journal-title":"Journal of Immunology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.emboj.7601489","article-title":"COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase","volume":"26","author":"GN Maine","year":"2007","journal-title":"EMBO J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e79445","DOI":"10.1371\/journal.pone.0079445","article-title":"IL-10 inhibits the NF-kappaB and ERK\/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes","volume":"8","author":"E Hovsepian","year":"2013","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2014.03.013","article-title":"Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group","volume":"133","author":"KS Tewari","year":"2014","journal-title":"Gynecol Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10156-012-0478-4","article-title":"Risk factors for refractory febrile neutropenia in urological chemotherapy","volume":"19","author":"T Yasufuku","year":"2013","journal-title":"J Infect Chemother"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0120057","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:20:37Z","timestamp":1540347637000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114923"}},"subtitle":[],"editor":[{"given":"Zoran","family":"Culig","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,22]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114923","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0120057","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,22]]}}}